Katina buys PGNX 5.08: Kevin Kotler, Broadfin Capital Increase Holding Of Progenics Pharmaceuticals, Inc. (PGNX)
Kevin Kotler is bullish on Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) and has decided to boost his fundâs investment in the stock. Kotlerâs Broadfin Capital has increased its holding by 60% to a little over 8.95 million shares, as reported in a ... ...
52 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home